Here is another good news/bad news column about the 112th Congress.

Knowing where all our ingredients come from is the first step toward improving drug quality.

With fakes of the cancer drug Avastin popping up in U.S. clinics in the past few months, patients are naturally worried about whether their medicines are safe.  Considering eighty percent of the ingredients in U.S. medicines come from overseas – mostly from China and India because their products are generally...

Post-approval drug safety surveillance is an extraordinarily difficult task.The Vioxx episode has probably made it more difficult for the Food and Drug Administration to do its job.

Our new research shows that, compared to illegal counterfeit pharmaceuticals, substandard legal medicines can pose an equally dangerous threat.

Drug makers aren't chasing blockbusters like Lipitor anymore, or uncovering compounds the same way.

Conventional wisdom that U.S. pharmaceutical companies made out well under the Obama health plan by bargaining with the White House is wrong.